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SIGNIFICANCE
Carbonic anhydrases (CAs) reversibly convert carbon diox-
ide and water to bicarbonate and protons, thereby regula-
ting pH and osmotic balance in different tissues. However, 
their role in skin health is unclear. Increased levels of a CA 
isoform, CA II, were found in human keratinocytes upon 
treatment with a toll-like receptor 3 (TLR3) agonist, poly-
inosinic-polycytidylic acid (poly(I:C)), and Th2 cytokines, 
IL-4 and IL-13. The TLR3 pathway is implicated in antiviral 
and wound responses, and Th2 cytokines are involved in 
eczema. This suggests that CA II has a role in inflammatory 
skin conditions. 
Carbonic anhydrases are ubiquitously expressed enzy-
mes that reversibly hydrate carbon dioxide to bicar-
bonate and protons. While the main function of carbo-
nic anhydrases is to regulate pH and osmotic balance, 
their involvement in other physiological processes 
remains to be explored. This study analysed changes 
in mRNA and protein levels of carbonic anhydrase II 
in human primary keratinocytes treated with various 
toll-like receptor agonists and cytokines. A significant 
upregulation of carbonic anhydrase II at the mRNA 
and protein levels was observed upon treatment with 
polyinosinic-polycytidylic acid, a toll-like receptor 3 
agonist. Furthermore, in agreement with the increased 
expression of carbonic anhydrase II in atopic derma-
titis skin, carbonic anhydrase II was upregulated by 
the Th2 cytokines interleukins -4 and -13. In conclu-
sion, these results suggest a potential role of carbonic 
anhydrase II in Th2-dependent and toll-like receptor 
3-induced pathways in inflammatory skin conditions. 
Key words: carbonic anhydrase II, keratinocytes, TLR3, 
poly(I:C), Th2 cytokines, inflammation.
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Skin forms the first line of defence and thus is an im-portant site for immune response. Toll-like receptors 
(TLRs) constitute a family of signal transducing proteins, 
which sense the environment and activate downstream 
pathways related to inflammation, antiviral response, 
maintenance of homeostasis and regeneration (1). While 
TLRs play a crucial role in the cutaneous innate immune 
system, cytokines form part of the adaptive immune 
response by inducing and executing immune and inflam-
matory responses.
Carbonic anhydrases (CAs) catalyse the inter-con-
version of carbon dioxide and bicarbonates with the 
release of a proton (H+). Due to this fundamental, yet 
crucial reaction, CAs are involved in regulating pH, 
osmotic and electrolytic balance across kingdoms (2). 
Of the 15 CAs identified in humans, very few have been 
reported in keratinocytes and even fewer have their 
functions characterized. Carbonic anhydrase II (CA 
II), first discovered in red blood cells, has also been 
reported in keratinocytes. Although involvement of CA 
II in regulating pH in the skin has been hypothesized, 
its role is still unclear (3). 
To investigate the regulation of CA II in the context 
of host pathogen interaction and the ensuing immune 
response, an expression study was conducted for CA II 
in human keratinocytes using a panel of TLR agonists 
and cytokines. 
METHODS
Adult normal human epidermal keratinocytes (NHEK) (ATCC, 
Manassas, USA) were cultured in dermal cell basal media, supp-
lemented with keratinocyte growth kit, as per the ATCC recom-
mendations. NHEK cells in plates were treated with TLR 1–9 
agonists (InvivoGen, San Diego, USA) and cytokines (Milteny 
Biotec, Gladbach, Germany) for 12 h. Quantitative real-time PCR 
(qRT-PCR) was conducted for studying changes in CA2 gene ex-
pression upon treatment. Primers used were 5’-CCTGAATCCTT-
GGATTACTGGAC-3’ and 5’-TCCCCATTGAAGTTAAGTT-
TACG-3’ for CA2 and 5’-TCGACAATGGCAGCATCTAC-3’ and 
5’-ATCCGTCTCCACAGACAAGG-3’ for the housekeeping gene 
RPLP0. Protein levels were evaluated by Western immunoblot-
ting using CA II (ab124687, Abcam, Cambridge, UK) and RPLP0 
(11290-2-AP, Proteintech, Chicago, USA) antibodies. Unbiased 
protein expression was quantified using an automated microscopy-
based High Content Analysis (HCA) system (IN Cell Investigator 
2200, GE Healthcare, New York, USA). High magnification ima-
ges were captured to visualize the localization of CA II protein 
using confocal laser scanning microscope (LSM800, Zeiss, Jena, 
Germany). All experiments were repeated at least 3 times. 
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RESULTS
To investigate the regulation of CA II expression in hu-
man epidermal keratinocytes, NHEK cells were treated 
with a panel of TLR agonists and cytokines for 12 h. qRT-
PCR analysis showed a significant up-regulation of CA2 
mRNA levels following treatment with poly(I:C), a TLR3 
agonist. Other tested agonists resulted in no significant 
changes in CA2 expression (Fig. 1A). Upon treatment 
with the panel of cytokines, only interleukin (IL)-4 and 
IL-13, both Th2 cytokines, showed a significant increase 
in CA2 mRNA levels (Fig. 1B). Other tested cytokines 
did not yield any significant changes in CA2 mRNA in 
primary keratinocytes.
The TLR3-mediated increase in CA2 gene expression 
was translated to a similar increase in CA II protein 
levels (Fig. 1C). Western immunoblot analysis showed 
significantly increased levels of CA II protein in human 
keratinocytes upon treatment with poly(I:C) and the Th2 
cytokines, IL-4 and IL-13. Unbiased and large scale cell-
by-cell quantitation of CA II protein in NHEK cells was 
carried out by HCA, which also showed a significant 
increase in CA II protein expression in the cytoplasm and 
nucleus. Visualization of the elevated CA II levels can be 
observed in the representative confocal images (Fig. 1D).
DISCUSSION
This study demonstrates that poly(I:C), a commonly used 
TLR3 agonist, induces CA II expression in keratinocy-
tes. Keratinocytes have been reported to express TLR1, 
Fig. 1. Effect of toll-like receptor (TLR) agonists and cytokines on carbonic anhydrase (CA) II expression in normal human epidermal 
keratinocytes (NHEK) cells. NHEK cells were treated with: (A) TLR agonists; or (B) cytokines (1 μg/mL each) for 12 h in 24-well plates. Cells were 
rinsed and harvested for RNA extraction and subsequently subjected to cDNA synthesis. Data from quantitative real-time PCR (qRT-PCR) for CA2 mRNA 
levels was plotted after normalizing with RPLP0 (fold change). (C) Cells were treated with polyinosinic-polycytidylic acid (poly(I:C)) (1 μg/ml, 2 μg/ml), 
interleukin (IL)-4 or IL-13 (1 μg/ml) and carbonic anhydrase (CA) II protein levels were evaluated by Western immunoblotting. Relative quantitation 
from 3 independent experiments has been plotted with a representative immunoblot above the graph. (D) NHEK cells were treated with the TLR3 agonist 
poly(I:C) (2 μg/ml) and Th2 cytokines (1 μg/ml) for 12 h in 96-well plates and coverslips. Cells were rinsed, followed by immunofluorescent labelling 
of CA II, nucleus and cytoskeleton. High content analysis (HCA) was performed to quantify differences in protein levels and localization with respect to 
untreated cells. Unbiased quantitation from 27 fields of view is presented per column in a colour-coded heatmap as fold changes in CA II protein levels 
as captured by HCA. Representative confocal images are overlaid on the heatmap showing CA II (red), nucleus delineated with DAPI (blue) and F-actin 
stained with phalloidin (green). Images were captured at 63× magnification and scale bar depicts 10 µm. All data is mean ± standard deviation from 3 
independent experiments. Significance was calculated by one-way analysis of variance (ANOVA) for qRT-PCR and HCA data, and by unpaired t-test for 
Western immunoblot data. *p < 0.05, **p < 0.01, ***p < 0.001 compared with untreated control. Nuc: nuclear; Cell: cellular: Bg: background.
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TLR2, TLR3 and TLR5; however, there have been mixed 
reports about the presence of TLR4, TLR6 and TLR9 (4, 
5). To circumvent the discrepancies, we tested the effect 
of a panel of TLR agonists on cultured human epidermal 
keratinocytes. Amongst the TLR agonists tested, only 
TLR3 lead to an up-regulation of CA II expression at 
both mRNA and protein levels. TLR3 is located mostly 
in the endosomes and requires the agonist to enter the 
cell to initiate a cellular response. Typically, TLR3 senses 
virus-derived patterns triggering antiviral genes, such as 
type I interferons, by a myeloid differentiation factor 88 
(MyD88)-independent pathway, which leads to nuclear 
factor (NF)-κB or interferon regulatory factor (IRF)-3 
dominated immune response (6, 7). 
TLR3 has also been implicated in sensing tissue da-
mage and injury, and activating downstream repair me-
chanisms. Injury to skin by ultraviolet (UV) radiation and 
other factors releases double-stranded (ds) RNA, which 
activates TLR3 (8). This activation triggers epidermal 
barrier repair by increasing expression of corneodesmo-
sins, junction proteins and cross-linking enzymes, such 
as transglutaminases and sphingomyelinases (9). Topi-
cal application of poly(I:C) has been found to augment 
wound closure of laser-induced wounds (10). Activation 
of TLR3 maintains keratinocytes in a less differentiated 
state contributing to skin and hair follicle regeneration 
(11). Induction of psoriasin (S100A7) via TLR3, which 
in turns promotes wound closure, has also been repor-
ted (12). Furthermore, decreased expression of TLR3 
in adults compared with infants alludes to the reduced 
ability for repair and regeneration with ageing (13). It 
is notable that poly(I:C) is a synthetic dsRNA analogue, 
which stimulates anti-viral response elements or dsRNA 
sensing molecules present in keratinocytes, such as 
protein kinase R (PKR), RNA helicases, retinoic acid-
inducible gene I (RIG-I) and melanoma differentiation 
associated protein 5 (MDA5), while poly(I:C)-induced 
IRF-3 activation and IFN-β expression do not decrease 
upon inhibition of TLR3 signalling (14). In this context, 
it is possible that the observed effect of poly(I:C) could 
be a combined effect of PKR, RIG-I, MDA5 and TLR3. 
Interestingly, foscarnet and uracils, antiviral drugs and 
their derivatives, inhibit the activity of a variety of CAs 
in vitro (15, 16) and CA inhibitors enhance the activity 
of a nucleo-polyhedrovirus (17). Gel-based recombi-
nant CA IV application to full-thickness skin wounds 
in mice has been found to significantly improve wound 
re-epithelialization (18). Linking these data reported 
earlier with our current observations suggests that CA II 
is downstream of poly(I:C)-induced pathway affecting 
both antiviral response and wound healing. 
Th2 dominant atopic dermatitis (AD) lesions show a 
significant increase in CA2 gene expression compared 
with Th1-dominant psoriatic lesions and controls (19). 
Our data also shows an up-regulation of CA II upon 
treat ment with IL-4 and IL-13, both Th2 cytokines, 
which is in accordance with previously reported results 
(3). Absence of a genetic association of the CA2 gene 
with AD (20) suggests that upregulation of CA II is an 
effect rather than a cause of AD. Interestingly, thymic 
stromal lymphopoietin (TSLP), which is also upregulated 
in AD lesions and promotes a Th2 response (21), is also 
inducible by poly(I:C) (22). 
One limitation of the current study is that the observa-
tions were recorded 12 h post-treatment. Upregulation 
of CA II mRNA and protein could be an indirect effect 
of poly(I:C)-induced secreted cytokines, such as IL-6, 
TNF-α (23), CXCL8, CXCL9, CXCL10, CCL2, CCL20, 
and CCL27 (24). While TNF-α and IL-8 (CXCL8) did 
not directly affect CA2 expression in NHEK cells (Fig. 
1B), possible effects of other cytokines and/or signalling 
mediators that could be induced in human keratinocytes 
via TLR3 cannot be ruled out. It is also possible that other 
dsRNA sensing receptors are operative in poly(I:C)-
induced upregulation of CA II in human keratinocytes. 
Another point to note is that this study used a relatively 
high concentration of cytokines (1 μg/ml) to confirm 
the expression of CA II upregulation in human kerati-
nocytes. Nevertheless, we present novel data of CA II 
upregulation in poly(I:C)-treated human keratinocytes 
when stimulated directly or indirectly via TLR3. It would 
be interesting to comprehensively screen the potential 
involvement of relevant cytokines/chemokines and their 
combinations through time-course and dose-course stu-
dies using a physiological concentration range.
In conclusion, this study shows that the TLR3 agonist 
poly(I:C) upregulates CA II in human keratinocytes, 
which could have implications for antiviral, wound 
healing and/or regeneration pathways. Further research 
is needed to comprehensively characterize CA II for 
its potential role in inflammatory and skin proliferative 
disorders. 
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